Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06634342 · ClinicalTrials.gov registry record · NA
One-step HCV RNA Testing Among SSP Participants (HOT Study)
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT06634342: Completed NA study, sponsored by University of Washington.
NCT06634342 is a NA study that has completed, run by University of Washington. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06634342, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The HOT (HCV One-step Test) Study is an observational prospective study to evaluate the use of a recently FDA-approved point-of-care RNA test for hepatitis C virus (HCV) in a sample of clients of a syringe services program (SSP). The investigators aim to answer the following questions: 1\. How will point-of-care HCV RNA testing with the Xpert HCV test, provided at an SSP, affect how people who use drugs receive their results, get linked to HCV care services, and initiate and complete HCV treatment? 2: What are the most effective ways to implement point of care HCV RNA testing in syringe services programs?
Primary Outcome
Percentage of individuals who complete a HCV RNA test and who also receive their test results.
Interventions
- DIAGNOSTIC_TEST HCV RNA Rapid testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-02-05 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What the finished NCT06634342 record still lists
NCT06634342 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which HCV RNA Rapid testing is the first listed.
NCT06634342 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06634342 about?
NCT06634342 is a clinical study titled "One-step HCV RNA Testing Among SSP Participants (HOT Study)". The HOT (HCV One-step Test) Study is an observational prospective study to evaluate the use of a recently FDA-approved point-of-care RNA test for hepatitis C virus (HCV) in a sample of clients of a syringe services program (SSP). The investigators aim to answer the following questions: 1\. How will...
What is the current status of trial NCT06634342?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2025-02-05. Estimated completion is 2026-04-30.
What interventions are being tested in trial NCT06634342?
The interventions under investigation include: HCV RNA Rapid testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06634342?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06634342's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI